Header Logo

Connection

MICHAEL ITTMANN to Prostate

Back to Details
This is a "connection" page, showing publications MICHAEL ITTMANN has written about Prostate.
MICHAEL ITTMANN
Connection Strength
5.708
Prostate
  1. MEX3D is an oncogenic driver in prostate cancer. Prostate. 2021 11; 81(15):1202-1213.
    View in: PubMed
    Score: 0.585
  2. Comparative analysis of p16 expression among African American and European American prostate cancer patients. Prostate. 2019 08; 79(11):1274-1283.
    View in: PubMed
    Score: 0.500
  3. Anatomy and Histology of the Human and Murine Prostate. Cold Spring Harb Perspect Med. 2018 05 01; 8(5).
    View in: PubMed
    Score: 0.464
  4. Oxidative stress promotes benign prostatic hyperplasia. Prostate. 2016 Jan; 76(1):58-67.
    View in: PubMed
    Score: 0.388
  5. Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo. Clin Cancer Res. 2014 Jan 01; 20(1):100-9.
    View in: PubMed
    Score: 0.339
  6. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin Cancer Res. 2010 Jul 15; 16(14):3539-47.
    View in: PubMed
    Score: 0.270
  7. Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate. 2004 Jul 01; 60(2):153-9.
    View in: PubMed
    Score: 0.178
  8. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. Prostate. 2004 Jun 15; 60(1):18-24.
    View in: PubMed
    Score: 0.178
  9. Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis. Hum Pathol. 2022 04; 122:84-91.
    View in: PubMed
    Score: 0.151
  10. FGF-10 is expressed at low levels in the human prostate. Prostate. 2000 Sep 01; 44(4):334-8.
    View in: PubMed
    Score: 0.137
  11. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J Cell Physiol. 1999 Jul; 180(1):53-60.
    View in: PubMed
    Score: 0.126
  12. Spatially Restricted Stromal Wnt Signaling Restrains Prostate Epithelial Progenitor Growth through Direct and Indirect Mechanisms. Cell Stem Cell. 2019 05 02; 24(5):753-768.e6.
    View in: PubMed
    Score: 0.124
  13. Influence of the neural microenvironment on prostate cancer. Prostate. 2018 Feb; 78(2):128-139.
    View in: PubMed
    Score: 0.112
  14. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein. Oncogene. 2017 08 17; 36(33):4767-4777.
    View in: PubMed
    Score: 0.108
  15. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol. 1997 Jan; 157(1):351-6.
    View in: PubMed
    Score: 0.106
  16. Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor. Mol Cell. 2016 09 15; 63(6):976-89.
    View in: PubMed
    Score: 0.103
  17. The essential role of GATA transcription factors in adult murine prostate. Oncotarget. 2016 Jul 26; 7(30):47891-47903.
    View in: PubMed
    Score: 0.103
  18. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model. J Clin Invest. 2016 07 01; 126(7):2626-41.
    View in: PubMed
    Score: 0.102
  19. Stromal TGF-? signaling induces AR activation in prostate cancer. Oncotarget. 2014 Nov 15; 5(21):10854-69.
    View in: PubMed
    Score: 0.091
  20. Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells. Nat Commun. 2014 Jul 22; 5:4416.
    View in: PubMed
    Score: 0.089
  21. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer. Int J Cancer. 2015 Feb 15; 136(4):875-9.
    View in: PubMed
    Score: 0.089
  22. The senescence-associated secretory phenotype promotes benign prostatic hyperplasia. Am J Pathol. 2014 Mar; 184(3):721-31.
    View in: PubMed
    Score: 0.086
  23. FGFR1 is essential for prostate cancer progression and metastasis. Cancer Res. 2013 Jun 15; 73(12):3716-24.
    View in: PubMed
    Score: 0.082
  24. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression. Cancer Res. 2013 Apr 15; 73(8):2551-62.
    View in: PubMed
    Score: 0.081
  25. Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2. Mol Oncol. 2013 Jun; 7(3):484-96.
    View in: PubMed
    Score: 0.080
  26. Notch and TGF? form a reciprocal positive regulatory loop that suppresses murine prostate basal stem/progenitor cell activity. Cell Stem Cell. 2012 Nov 02; 11(5):676-88.
    View in: PubMed
    Score: 0.079
  27. Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression. Clin Cancer Res. 2012 Jul 15; 18(14):3880-8.
    View in: PubMed
    Score: 0.077
  28. TGF-?1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One. 2010 Oct 29; 5(10):e13751.
    View in: PubMed
    Score: 0.069
  29. Dicer ablation impairs prostate stem cell activity and causes prostate atrophy. Stem Cells. 2010 Jul; 28(7):1260-9.
    View in: PubMed
    Score: 0.067
  30. Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts. Cancer Res. 2008 Oct 15; 68(20):8516-24.
    View in: PubMed
    Score: 0.060
  31. Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res. 2007 Jul 01; 13(13):3796-802.
    View in: PubMed
    Score: 0.055
  32. Increased expression of the metastasis-associated gene Ehm2 in prostate cancer. Prostate. 2006 Nov 01; 66(15):1641-52.
    View in: PubMed
    Score: 0.052
  33. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol. 2006 Oct; 30(10):1281-91.
    View in: PubMed
    Score: 0.052
  34. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res. 2006 May 15; 66(10):5159-64.
    View in: PubMed
    Score: 0.051
  35. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer. 2004 Dec; 11(4):709-24.
    View in: PubMed
    Score: 0.046
  36. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res. 2004 Sep 01; 64(17):6082-90.
    View in: PubMed
    Score: 0.045
  37. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol. 2001 Jul; 159(1):139-47.
    View in: PubMed
    Score: 0.036
  38. Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling. Oncogene. 2021 03; 40(9):1690-1705.
    View in: PubMed
    Score: 0.035
  39. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Cancer Res. 2000 Aug 01; 60(15):4245-50.
    View in: PubMed
    Score: 0.034
  40. Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin. Br J Pharmacol. 1999 May; 127(1):220-6.
    View in: PubMed
    Score: 0.031
  41. Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers. Nat Commun. 2018 10 04; 9(1):4080.
    View in: PubMed
    Score: 0.030
  42. Endothelin-1 production and agonist activities in cultured prostate-derived cells: implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia. Prostate. 1998 Mar 01; 34(4):241-50.
    View in: PubMed
    Score: 0.029
  43. Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression. Horm Cancer. 2015 Jun; 6(2-3):67-86.
    View in: PubMed
    Score: 0.023
  44. Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin. Proc Natl Acad Sci U S A. 2014 Feb 04; 111(5):E592-600.
    View in: PubMed
    Score: 0.021
  45. SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer. Mol Endocrinol. 2013 Jun; 27(6):925-39.
    View in: PubMed
    Score: 0.020
  46. COUP-TFII inhibits TGF-?-induced growth barrier to promote prostate tumorigenesis. Nature. 2013 Jan 10; 493(7431):236-40.
    View in: PubMed
    Score: 0.020
  47. Activation of Wnt signaling by chemically induced dimerization of LRP5 disrupts cellular homeostasis. PLoS One. 2012; 7(1):e30814.
    View in: PubMed
    Score: 0.019
  48. GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction. Cancer Res. 2011 Dec 15; 71(24):7694-704.
    View in: PubMed
    Score: 0.018
  49. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7593-603.
    View in: PubMed
    Score: 0.015
  50. Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer. J Urol. 2007 Oct; 178(4 Pt 1):1521-7.
    View in: PubMed
    Score: 0.014
  51. PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer. Int J Cancer. 2006 Mar 15; 118(6):1471-80.
    View in: PubMed
    Score: 0.013
  52. Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers. Int J Cancer. 2005 Feb 20; 113(5):811-8.
    View in: PubMed
    Score: 0.012
  53. Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate. Cancer Res. 2003 Dec 15; 63(24):8784-90.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.